Ramsay Générale de Santé SA (GDS) Earnings Call Transcripts

32 earnings calls from February 2020 to September 17, 2026

ENXTPA FR Health Care Health Care Providers and Services

Ramsay Générale de Santé SA's Latest Earnings Call - Q1 FY2026

In Q1 2026, GDS Holdings Limited reported a 7.9% increase in revenue and an 8% rise in adjusted EBITDA, driven by strong data center demand fueled by AI developments. The company maintained its full-year guidance, indicating confidence in continued growth. Management highlighted a robust bookings pipeline, with 340 megawatts already secured year-to-date, and a target of 500 to 800 megawatts annually over the next three years. This positions GDS well for sustained expansion, supported by a strong balance sheet and strategic investments.

Reported metrics

MetricValueContext
Revenue 7.9% growth (beat) vs previous quarter, driven by AI demand
Adjusted EBITDA 8% growth (inline) excluding onetime items, inline with expectations
Net Debt to EBITDA 4.7x (positive) decreased from 6.8x at end of 2024
CapEx RMB 770 million (neutral) Q1 2026, expected to increase in subsequent quarters
Cash and Time Deposits RMB 19 billion (positive) USD 2.7 billion, strong cash position

Guidance from management

GDS maintained its full-year guidance, with plans to add 500 to 800 megawatts of new bookings annually over the next three years. The company is confident in reaching or exceeding its 2026 sales target of at least 500 megawatts.

What management said

Yes, Liu, I think this will -- I think in the last earnings call, we already say the new incremental demand, which is driven by the AI, right, the large-scale data center demand. In general, I mean, the price pretty stable, number one. Number two, I think the -- of course, in the whole market, you cannot stop some bidder, right, and use some price tools try to win there. But it's not normal, right? It's not normal....
— William Huang, Q1 FY2026 earnings call
Yes. I try to add a couple of color. I mean number one, the scale is unprecedented, right? So scale also make a cost a bit lower, right? That's fair nature. I mean, this is the number one, even for the vendor perspective, scale that's larger scale gives a lot of the manufacturing product company, a lot of benefit, right? So they're willing to reduce the cost release price. This is the number one. And number two, I ...
— William Huang, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the pricing environment in different markets and the potential impact of aggressive bidding. There were also questions regarding the development cost reductions and the sustainability of current growth rates.

Main topics on the call

Read the full Ramsay Générale de Santé SA transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Ramsay Générale de Santé SA

Ramsay Générale de Santé SA (GDS) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on ENXTPA and is based in FR. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 32 calls on record spanning February 26, 2020 to September 17, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 32 Ramsay Générale de Santé SA earnings call transcripts on record, spanning February 26, 2020 to September 17, 2026. Based on this history, Ramsay Générale de Santé SA reports quarterly. The most recent call on file is dated September 17, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
GDS
Exchange
ENXTPA
Country
FR
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
32
First call
February 26, 2020
Most recent
September 17, 2026
Reporting cadence
quarterly
Quarter Date
Analyst/Investor Day Sep 17, 2026 Read transcript →
Q2 FY2026 Aug 13, 2026 Read transcript →
Q1 FY2026 May 20, 2026 Read transcript →
Q4 FY2025 Mar 17, 2026 Read transcript →
Shareholder/Analyst Calls Dec 11, 2025 Read transcript →
Q3 FY2025 Nov 19, 2025 Read transcript →
Q2 FY2025 Aug 20, 2025 Read transcript →
Q1 FY2025 May 20, 2025 Read transcript →
Q4 FY2024 Mar 19, 2025 Read transcript →
Q3 FY2024 Nov 19, 2024 Read transcript →
Q2 FY2024 Aug 21, 2024 Read transcript →
Q1 FY2024 May 22, 2024 Read transcript →
Q4 FY2023 Mar 26, 2024 Read transcript →
Q3 FY2023 Nov 22, 2023 Read transcript →
Q2 FY2023 Aug 22, 2023 Read transcript →
Q1 FY2023 May 25, 2023 Read transcript →
Q4 FY2022 Mar 15, 2023 Read transcript →
Q3 FY2022 Nov 22, 2022 Read transcript →
Earnings Calls Aug 23, 2022 Read transcript →
Q1 FY2022 May 19, 2022 Read transcript →
Q4 FY2021 Mar 22, 2022 Read transcript →
Q3 FY2021 Nov 16, 2021 Read transcript →
Earnings Calls Aug 25, 2021 Read transcript →
Q2 FY2021 Aug 17, 2021 Read transcript →
Q1 FY2021 May 20, 2021 Read transcript →
Q4 FY2020 Mar 11, 2021 Read transcript →
Earnings Calls Feb 24, 2021 Read transcript →
Q3 FY2020 Nov 17, 2020 Read transcript →
Q2 FY2020 Aug 18, 2020 Read transcript →
Q1 FY2020 May 14, 2020 Read transcript →
Q4 FY2019 Mar 19, 2020 Read transcript →
Earnings Calls Feb 26, 2020 Read transcript →